Research
Hormonal
Glucose-dependent insulinotropic polypeptide (GIP) acts as a bifunctional blood sugar stabilizing factor in type 2 diabetes.
GIP may be considered in therapeutic strategies for managing blood sugar in type 2 diabetes.
StrongSupportsmedium confidence
It turned out that by regulating glucagon and insulin production according to blood sugar levels, it acts as a bifunctional blood sugar stabilizing factor in type 2 diabetes as well.
Why this rating
The claim is based on recent studies reviewed in the abstract.
Source
A „másik” inkretin – a glükózdependens insulinotrop polipeptid terápiás újrafelfedezése
Gábor Winkler et al. · Orvosi Hetilap · 2023
reviewCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →